RNA-sequencing

DIAGNOSTIC_TEST2 trials

Sponsors

Case Comprehensive Cancer Center, Vall d'Hebron Institute of Oncology

Conditions

Malignant MelanomaTriple Negative Breast Cancer

Early Phase 1

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

WithdrawnNCT04285749

Case Comprehensive Cancer CenterMalignant Melanoma

Start: 2020-11-06End: 2021-04-01Updated: 2020-07-27

Unknown Phase

Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform

RecruitingNCT05916755

Vall d'Hebron Institute of OncologyTriple Negative Breast Cancer

Start: 2023-01-13End: 2029-12-31Target: 100Updated: 2023-06-23